menu
    • menu

    Company profile for Harrow

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Harrow is a growing leader in the ophthalmic healthcare market. Our success-to-date is directly tied to our unique approach to serving patients and supporting eyecare professionals. We make pharmaceutical products for the over 8 million annual ophthalmic surgeries in the U.S., as well as medications prescribed to treat patients managing chronic and acute eye conditions such as dry eye disease, glaucoma, allergies, infections, ...
    Harrow is a growing leader in the ophthalmic healthcare market. Our success-to-date is directly tied to our unique approach to serving patients and supporting eyecare professionals. We make pharmaceutical products for the over 8 million annual ophthalmic surgeries in the U.S., as well as medications prescribed to treat patients managing chronic and acute eye conditions such as dry eye disease, glaucoma, allergies, infections, and other ophthalmic inflammatory conditions. We serve over 10,000 doctors, hospitals, and ambulatory service centers (ASCs) and regularly ship to over 1,500 institutional accounts each month.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HarrowUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    102 Woodmont Blvd., Suite 610 Nashville, TN 37205
    Telephone
    Telephone
    (615) 733 4730
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.harrowinc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/harrow-health-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Harrow To Present At Two Investor Conferences In December
    Harrow To Present At Two Investor Conferences In December

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193372/0/en/Harrow-to-Present-at-Two-Investor-Conferences-in-December.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Harrow Announces Closing Of Acquisition Of Melt Pharmaceuticals
    Harrow Announces Closing Of Acquisition Of Melt Pharmaceuticals

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3189844/0/en/Harrow-Announces-Closing-of-Acquisition-of-Melt-Pharmaceuticals.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Harrow Announces Third Quarter 2025 Financial Results
    Harrow Announces Third Quarter 2025 Financial Results

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185049/0/en/Harrow-Announces-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Harrow To Release Q3 2025 Financial Results On November 10, 2025
    Harrow To Release Q3 2025 Financial Results On November 10, 2025

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174429/0/en/Harrow-To-Report-Third-Quarter-2025-Financial-Results-After-Market-Close-on-November-10-2025.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Imprimisrx Announces Leadership Changes
    Imprimisrx Announces Leadership Changes

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161579/0/en/ImprimisRx-Announces-Leadership-Changes.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Harrow To Acquire Melt Pharmaceuticals
    Harrow To Acquire Melt Pharmaceuticals

    26 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/26/3156941/0/en/Harrow-to-Acquire-Melt-Pharmaceuticals.html

    GLOBENEWSWIRE
    26 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search